Our leadership team has extensive experience in developing, obtaining regulatory approvals for and successfully commercializing a variety of oncology products. In total, they have decades of combined experience spanning a range of cancers and other diseases.

Allene Diaz

Senior Vice President, Global Commercial Development and Program Strategy

Allene Diaz has served as the Senior Vice President of Global Commercial Development and Program Strategy since May 2015 and currently serves as an independent Director of Erytech Pharma SA, a clinical-stage biopharmaceutical company developing innovative therapies for cancer.

Prior to her tenure at TESARO, Ms. Diaz spent 7 years at EMD/Merck Serono, divisions of Merck KGaA, Darmstadt, Germany in a variety of roles. She served as Senior Vice President, Managed Markets where she was responsible for over a $1.5 billion dollars in contracted sales of EMD Serono products. Previously, she was Senior Vice President, Head of US Oncology Commercial and prior to that, she served as Vice President, Oncology Marketing. She also spent time as the Head of Global Strategic Planning, Oncology and as the Head of the Global Oncology Business Unit for Merck Serono responsible for driving sales of Erbitux. Ms. Diaz has held management positions at several leading biopharmaceutical companies, including Amylin Pharmaceuticals, Biogen, Pfizer and Parke-Davis Pharmaceuticals.

Ms. Diaz has contributed to the launch and/or commercialization of multiple global brands throughout her career including Zejula®, Bydureon®, Rezulin®, Rituxan®, and Erbitux®. Ms. Diaz earned her Bachelor of Science from Florida State University.